
Hepatologist

No OPD information available
Cirrhosis
Hepatitis
Liver Transplant
Portal Hypertension
Ascites
Hepatitis B
Hepatitis C
Hepatorenal Syndrome
Hypertension
Liver Failure
Low Testosterone
Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)
Abdominal Obesity Metabolic Syndrome
Budd-Chiari Syndrome
Cholangitis
Cholestasis
Common Variable Immune Deficiency
Cytomegalic Inclusion Disease
Cytomegalovirus Infection
Erythropoietic Protoporphyria
Esophageal Varices
Familial Hypercholesterolemia
Gastrointestinal Bleeding
Hepatocerebral Degeneration
Homozygous Familial Hypercholesterolemia (HoFH)
Hormone Replacement Therapy (HRT)
Liver Cancer
Low Blood Pressure
Malnutrition
Muscle Atrophy
Necrosis
Omphalocele
Porphyria
Primary Biliary Cholangitis
Protoporphyria
Sclerosing Cholangitis
Spinocerebellar Degeneration and Corneal Dystrophy
Type 2 Diabetes (T2D)
Umbilical Hernia
Varicose Veins
Vasoconstriction
Peter W. Angus is a male healthcare provider who helps patients with various liver and metabolic conditions like cirrhosis, hepatitis, and liver cancer. He also treats issues like high blood pressure, low testosterone, and diabetes. Peter W. Angus is skilled in managing complex diseases such as familial hypercholesterolemia and primary biliary cholangitis.
Patients trust Peter W. Angus because he communicates clearly and compassionately, taking the time to listen to their concerns and explain their treatment options in simple terms. He builds strong relationships with his patients based on trust and empathy.
To stay updated with the latest medical knowledge, Peter W. Angus regularly attends conferences, reads research papers, and collaborates with other healthcare professionals. He values lifelong learning to provide the best possible care for his patients.
Peter W. Angus works closely with colleagues in a team-based approach, sharing knowledge and expertise to ensure comprehensive care for each patient. He values collaboration and believes in the power of teamwork to achieve the best outcomes for his patients.
Through his work, Peter W. Angus has positively impacted many patients' lives by providing effective treatments and improving their overall health. His dedication to patient care and commitment to staying informed about the latest advancements in medicine have helped countless individuals lead healthier lives.
One of Peter W. Angus's notable publications, "Oncogenic plasmid DNA and liver injury agent dictates liver cancer development in a mouse model," showcases his contribution to liver cancer research. Additionally, he has been involved in clinical trials, such as the study evaluating the safety and efficacy of Obeticholic Acid in subjects with nonalcoholic steatohepatitis.
In summary, Peter W. Angus is a dedicated healthcare provider who specializes in treating liver and metabolic conditions, communicates effectively with patients, stays updated with medical research, collaborates with colleagues, and has made a positive impact on many patients' lives through his work.
Enrollment Status: Terminated
Published: October 01, 2024
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 3
